These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1761 related articles for article (PubMed ID: 34112144)
1. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer. Wang Z; Tu L; Chen M; Tong S BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144 [TBL] [Abstract][Full Text] [Related]
2. Scoring System Based on RNA Modification Writer-Related Genes to Predict Overall Survival and Therapeutic Response in Bladder Cancer. Zhang P; Liu Z; Wang D; Li Y; Xing Y; Xiao Y Front Immunol; 2021; 12():724541. PubMed ID: 34512654 [TBL] [Abstract][Full Text] [Related]
3. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer. Chen F; Wang Q; Zhou Y BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397 [TBL] [Abstract][Full Text] [Related]
4. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer. Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787 [TBL] [Abstract][Full Text] [Related]
6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
7. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival. Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W Hereditas; 2019; 156():24. PubMed ID: 31333338 [TBL] [Abstract][Full Text] [Related]
8. A Novel TGF-β Risk Score Predicts the Clinical Outcomes and Tumour Microenvironment Phenotypes in Bladder Cancer. Liu Z; Qi T; Li X; Yao Y; Othmane B; Chen J; Zu X; Ou Z; Hu J Front Immunol; 2021; 12():791924. PubMed ID: 34975891 [TBL] [Abstract][Full Text] [Related]
9. Exploring the Shared Gene Signatures and Molecular Mechanisms between Bladder Urothelial Carcinoma and Metabolic Syndrome. Li C; Wan Z; Deng Q; Li Z; Wang Y Arch Esp Urol; 2023 Oct; 76(8):605-621. PubMed ID: 37960960 [TBL] [Abstract][Full Text] [Related]
10. Song DM; Shen T; Feng K; He YB; Chen SL; Zhang Y; Luo WF; Han L; Tong M; Jin Y Front Immunol; 2024; 15():1419126. PubMed ID: 39234248 [TBL] [Abstract][Full Text] [Related]
11. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients. Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179 [TBL] [Abstract][Full Text] [Related]
12. Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancer. Wang J; Tan Z; Huang Y; Li C; Zhan P; Wang H; Li H Aging (Albany NY); 2024 Jul; 16(14):11385-11408. PubMed ID: 39033778 [TBL] [Abstract][Full Text] [Related]
13. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer. Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer. Chen X; Qin Z; Zhu X; Wang L; Li C; Wang H Sci Rep; 2023 Dec; 13(1):21816. PubMed ID: 38071230 [TBL] [Abstract][Full Text] [Related]
15. Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer. Zheng F; Wang Z; Li S; Xiong S; Yuan Y; Zeng J; Tan Y; Liu X; Xu S; Fu B Eur J Med Res; 2024 Jul; 29(1):393. PubMed ID: 39075554 [TBL] [Abstract][Full Text] [Related]
16. Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. Lu H; Wu J; Liang L; Wang X; Cai H Front Immunol; 2022; 13():803355. PubMed ID: 35154117 [TBL] [Abstract][Full Text] [Related]
17. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H Front Immunol; 2022; 13():916800. PubMed ID: 35860239 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
19. Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer. Liu R; Yang T; Huang J; Xiao Z; Liu J; Li Z; Tong S BMC Cancer; 2024 Aug; 24(1):947. PubMed ID: 39095785 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]